Global Nuclear Medicine System Market Insights, Forecast to 2028

Nuclear medicine is a medical specialty that uses radioactive tracers (radiopharmaceuticals) to assess bodily functions and to diagnose and treat disease. Specially designed cameras allow doctors to track the path of these radioactive tracers. Single Photon Emission Computed Tomography or SPECT and Positron Emission Tomography or PET scans are the two most common imaging modalities in nuclear medicine.
Market Analysis and Insights: Global Nuclear Medicine System Market
Due to the COVID-19 pandemic, the global Nuclear Medicine System market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Single-Photon Emission Computed Tomography (SPECT) Systems accounting for % of the Nuclear Medicine System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Nuclear Medicine System market size is valued at US$ million in 2021, while the US and Europe Nuclear Medicine System are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Nuclear Medicine System landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Nuclear Medicine System include Siemens Healthineers, Koninklijke Philips, GE Healthcare, Neusoft Medical Systems, Mediso Medical Imaging Systems, Digirad, SurgicEye and Positron, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Nuclear Medicine System Scope and Segment
Nuclear Medicine System market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Nuclear Medicine System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Single-Photon Emission Computed Tomography (SPECT) Systems
Hybrid Positron Emission Tomography (PET) Systems
Planar Scintigraphy
Segment by Application
Hospitals
Imaging Centers
Research Institutes
Others
By Company
Siemens Healthineers
Koninklijke Philips
GE Healthcare
Neusoft Medical Systems
Mediso Medical Imaging Systems
Digirad
SurgicEye
Positron
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E